Publications by authors named "Elsa Curtit"

Claim this Profile
C
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.
Séverine Guiu, Judith Balmaña, Pablo Lemercier, Philippe Follana, Anthony Gonçalves, Elsa Curtit

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibility.
Chloé Drozd, Quentin Jacquinot, Sophie Paget-Bailly, Laura Mansi, Marie-Justine Paillard, Elsa Curtit

BMJ Support Palliat Care· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy.
Loïc Chaigneau, Eva Lapp, Taha Jai, Erion Dobi, Berenger Martin, Elsa Curtit

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).
Aikaterini Liapi, Veronica Aedo-Lopez, Wendy Jeanneret-Sozzi, Athina Stravodimou, John O Prior, Elsa Curtit

J Cancer Res Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.
Morgane Lopez, Laurie Spehner, Fabrice André, Julien Viot, Evan Seffar, Elsa Curtit

Breast Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.
Antoine El Kaddissi, Dewi Vernerey, Antoine Falcoz, Laura Mansi, Fernando Bazan, Elsa Curtit

Clin Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise Intervention on Insomnia in Patients with a Cancer: A Systematic Review of the Literature.
Chloé Drozd, Elsa Curtit, Valérie Gillet, Quentin Jacquinot, Nathalie Meneveau

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The French National College of Oncology Teachers (CNEC): Missions, organization, and projects].
Florence Huguet, Camille Tlemsani, Jean-Yves Pierga, Elsa Curtit, Elise Deluche

Bull Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial.
Laurie Spehner, Emeline Orillard, Antoine Falcoz, Quentin Lepiller, Adeline Bouard, Elsa Curtit

BMJ Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.
Elsa Curtit, Martine Marie Bellanger, Virginie Nerich, Delphine Hequet, Jean-Sebastien Frenel

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.
Chloé Drozd, Elsa Curtit, Quentin Jacquinot, Charlène Marquine, Laura Mansi

BMC Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.
Quentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, Malika Bouhaddi, Pauline Roux, Elsa Curtit

Front Cardiovasc Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.
Louis Garnier, Chrystelle Vidal, Olivier Chinot, Elisabeth Cohen-Jonathan Moyal, Apolline Djelad, Elsa Curtit

Oncologist· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adverse effects of new breast cancer therapies : when to react ?].
Nassim Dris, May-Lucie Meyer, Camila Flores Torres, Elsa Curtit, Jean-Philippe Zurcher

Rev Med Suisse· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.
Zohair Selmani, Chloé Molimard, Alexis Overs, Fernando Bazan, Loic Chaigneau, Elsa Curtit

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Guillaume Mouillet, Antoine Falcoz, Joëlle Fritzsch, Hamadi Almotlak, Pascale Jacoulet, Elsa Curtit

Qual Life Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
Volkmar Mueller, Andrew Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak, Elsa Curtit

Eur J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.
Louis Garnier, Emilie Charton, Antoine Falcoz, Sophie Paget-Bailly, Dewi Vernerey, Elsa Curtit

Neurooncol Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Real-life study of 7-year survival in patients treated with trastuzumab for HER2+ early breast cancer].
Mahasti Saghatchian, Elsa Curtit, David Coeffic, Alain Flinois, Christelle Levy

Bull Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adjuvant hormonal therapy for early breast cancer: Assessment of patients' satisfaction].
Julie Vardanega, Julie Henriques, Charlotte Pourcelot, Camille Dirand, Gilles Nallet, Elsa Curtit

Bull Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine use in glioma patients in France.
Emilie Le Rhun, Patrick Devos, Véronique Bourg, Amélie Darlix, Véronique Lorgis, Elsa Curtit

J Neurooncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of PONDx, a prospective multicenter study of the Oncotype DX breast cancer assay: Real-life utilization and decision impact in French clinical practice.
Elsa Curtit, Jean-Michel Vannetzel, Jean-Claude Darmon, Sophie Roche, Hugues Bourgeois

Breast· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Anne-Laure Clairet, Marie Boiteux-Jurain, Elsa Curtit, Marie Jeannin, Blandine Gérard

Med Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Response Induced by Single Agent Vemurafenib in a Spinal Ganglioglioma: A Case Report and Review of the Literature.
Louis Garnier, François Ducray, Clotilde Verlut, Marcella-Ionela Mihai, Françoise Cattin, Elsa Curtit

Front Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milestones over the development of SB3, a trastuzumab biosimilar.
Xavier Pivot, Igor Bondarenko, Thiery Petit, Elsa Curtit

Future Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis